Elanco Animal Health Incorporated ELAN
26.76 USD -0.08 (-0.30%)
At closeNov 10, 2026, 4:03 PM EST
26.76 0.00 0.00%
After hours · Nov 10, 4:03 PM ET
26.33 Day range 27.15
19.40 52-week range 27.98
- YTD
- +18.25%
- 1 year
- +20.16%
News
benzinga.com JP Morgan Maintains Overweight on Elanco Animal Health, Raises Price Target to $35 JP Morgan analyst Chris Schott maintains Elanco Animal Health (NYSE:ELAN) with a Overweight and raises the price target from $33 to $35.
fool.com Elanco Animal Health: 3 Key Takeaways for Long-Term Investors Third-quarter organic constant currency revenue grew 9% year over year. Elanco Animal Health lowered gross debt by $216 million in Q3.
marketbeat.com Elanco Animal Health Q3 Earnings Call Highlights Elanco Animal Health NYSE: ELAN raised its full-year outlook after third-quarter revenue rose 11%, driven by demand for its pet health products Zenrelia and Credelio Quattro and higher prices across…
benzinga.com Elanco Animal Health Sees Strong Momentum Heading Into 2027 Elanco Animal Health beats Q3 earnings and revenue estimates, driven by Pet Health demand and pricing gains, while raising its full-year 2026 outlook.
benzinga.com Elanco Animal Health Q3 2026 Earnings Call Transcript Elanco Animal Health (NYSE:ELAN) reported third-quarter financial results on Friday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought…
zacks.com Elanco Animal Health Incorporated (ELAN) Q3 Earnings and Revenues Surpass Estimates Elanco Animal Health Incorporated (ELAN) came out with quarterly earnings of $0.27 per share, beating the Zacks Consensus Estimate of $0.2 per share. This compares to earnings of $0.19 per share a…
benzinga.com Elanco Animal Health Sees Q4 Adj EPS $0.16-$0.19 vs $0.18 Est; Sees Sales $1.190B-$1.215B vs $1.193B Est Elanco Animal Health (NYSE:ELAN) is looking for Q4 Adj EPS of $0.16-$0.19 vs $0.18 analyst estimate. sees sales of $1.190 billion-$1.215 billion vs $1.193 billion analyst estimate.- benzinga.com Elanco Animal Health Raises FY2026 Adj EPS Guidance from $1.10-$1.16 to $1.17-$1.20 vs $1.13 Est; Raises FY2026 Sales Guidance from $5.090B-$5.140B to $5.155B-$5.180B vs $5.132B Est Elanco Animal Health (NYSE:ELAN) raises FY2026 Adj EPS guidance from $1.10-$1.16 to $1.17-$1.20 vs $1.13 analyst estimate. Raises FY2026 sales outlook from $5.090 billion-$5.140 billion to $5.155…
benzinga.com Elanco Animal Health Q3 Adj. EPS $0.27 Beats $0.20 Estimate, Sales $1.265B Beat $1.208B Estimate Elanco Animal Health (NYSE:ELAN) reported quarterly earnings of $0.27 per share which beat the analyst consensus estimate of $0.20 by 35 percent. This is a 42.11 percent increase over earnings of…
prnewswire.com Elanco Animal Health Reports Third Quarter 2026 Results Accelerated Price, Organic Constant Currency Revenue Growth, and Gross Margin Expansion; Raising Full Year Outlook and Innovation Target; Achieved 2.9x Net Leverage Ratio Milestone Third Quarter 2026…
prnewswire.com October Consumer Research Confirms Pet Health Remains Non-Negotiable Household Priority Latest U.S. Survey of 2,000+ Consumers Shows 93% of Pet Owners Maintained or Increased Pet Spending in Past Three Months, Omnichannel Shift Redefines Purchasing INDIANAPOLIS, Nov. 6, 2026…
benzinga.com Enbridge, Moderna On Deck Friday As Demand, Vaccine Pipeline Face Test Enbridge headlines Friday’s reports, with investors weighing whether resilient pipeline utilization can offset a softer revenue comparison. Moderna, Brookfield Asset Management, Humana, Vistra, PPL,…
247wallst.com Moderna, Humana and Elanco Earnings Previews: What Investors Should Watch One stock has soared more than sevenfold this year, another just lost a quarter of its value on leaked data, and a third carries the fate of millions of retirees. Friday's earnings could test each…
prnewswire.com Elanco to Participate in UBS Global Healthcare Conference INDIANAPOLIS, Nov. 3, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will attend the UBS Global Healthcare Conference on November 9, 2026. Bob VanHimbergen, executive vice…- benzinga.com Morgan Stanley Maintains Equal-Weight on Elanco Animal Health, Lowers Price Target to $25 Morgan Stanley analyst Erin Wright maintains Elanco Animal Health (NYSE:ELAN) with a Equal-Weight and lowers the price target from $26 to $25.
benzinga.com This Qiagen Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday Analysts downgraded Qiagen, Alcoa and Dutch Bros, cutting price targets for Qiagen to $52 and Dutch Bros to $46.
benzinga.com This Chipotle Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday Wall Street analysts downgraded Accenture, Braze, Chipotle, SmartFinancial and more, with several price-target cuts.
benzinga.com Occidental Petroleum To Rally Over 18%? Here Are 10 Top Analyst Forecasts For Tuesday Analysts cut targets for WING, ELAN, SBAC and RH; raised targets for TRV, OXY and GILD, with ELAN downgraded to Hold.
benzinga.com This Apple Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday Analysts downgraded Werner, Zoetis, Apple, Heartland Express and Elanco, cutting ratings to Neutral/Hold and lowering price targets.- benzinga.com Jefferies Downgrades Elanco Animal Health to Hold, Lowers Price Target to $24 Jefferies analyst Keith Devas downgrades Elanco Animal Health (NYSE:ELAN) from Buy to Hold and lowers the price target from $31 to $24.
benzinga.com This Urban Outfitters Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday Analysts initiated coverage: ELAN Buy/$32, IRTC Overweight/$160, BAND Equal-Weight/$56, HRTG Market Perform, and URBN Buy/$100.- benzinga.com Goldman Sachs Initiates Coverage On Elanco Animal Health with Buy Rating, Announces Price Target of $32 Goldman Sachs analyst Matt Dellatorre initiates coverage on Elanco Animal Health (NYSE:ELAN) with a Buy rating and announces Price Target of $32.
benzinga.com Elanco Animal Health Reports Q2 2026 Results: Full Earnings Call Transcript Elanco Animal Health (NYSE:ELAN) held its second-quarter earnings conference call on Wednesday. Below is the complete transcript from the call. Benzinga APIs provide real-time access to earnings call…- benzinga.com Elanco Animal Health Announces On-Time Completion Of 25K-Square-Foot Manufacturing Expansion Of Its Elwood, Kansas Manufacturing Site The completed 25,000-square-foot Elwood site expansion bolsters Elanco's monoclonal antibody (mAb) production; supports delivery of next-generation pipelineINDIANAPOLIS, Aug. 26, 2026 /PRNewswire/ --…
benzinga.com Netflix, Eli Lilly, Elanco Animal Health And More Stock On CNBC’s ‘Final Trades’ Bryn Talkington picked Horizon Kinetics, Stephanie Link chose Elanco Animal Health, and Jason Snipe recommended Netflix.- benzinga.com UBS Maintains Buy on Elanco Animal Health, Raises Price Target to $33 UBS analyst Andrea Alfonso maintains Elanco Animal Health (NYSE:ELAN) with a Buy and raises the price target from $31 to $33.
benzinga.com Keybanc Maintains Overweight on Elanco Animal Health, Raises Price Target to $30 Keybanc analyst Steve Dechert maintains Elanco Animal Health (NYSE:ELAN) with a Overweight and raises the price target from $29 to $30.
benzinga.com Elanco Sees Strong Pet Health Momentum, Bets on Innovative Products Elanco beat second-quarter estimates, raised 2026 guidance and cited strong Pet Health demand, Zenrelia growth and expanding margins.
benzinga.com Wynn Resorts Posts Upbeat Q2 Earnings, Joins Bloomin' Brands, Shopify, Owens Corning And Other Big Stocks Moving Higher On Wednesday US stocks rise, Wynn Resorts beat earnings expectations, share price jumps 10.9%. Other companies recording gains in today's session.- benzinga.com Elanco Animal Health Sees Q3 Adj EPS $0.19-$0.22 vs $0.20 Est; Sees Sales $1.195B-$1.220B vs $1.192B Est Elanco Animal Health (NYSE:ELAN) is looking for Q3 Adj EPS of $0.19-$0.22 vs $0.20 analyst estimate. sees sales of $1.195 billion-$1.220 billion vs $1.192 billion analyst estimate.
- benzinga.com Elanco Animal Health Raises FY2026 Adj EPS Guidance from $1.03-$1.09 to $1.10-$1.16 vs $1.09 Est; Raises FY2026 Sales Guidance from $5.010B-$5.085B to $5.090B-$5.140B vs $5.062B Est Elanco Animal Health (NYSE:ELAN) raises FY2026 Adj EPS guidance from $1.03-$1.09 to $1.10-$1.16 vs $1.09 analyst estimate. Raises FY2026 sales outlook from $5.010 billion-$5.085 billion to $5.090…
benzinga.com Morgan Stanley Maintains Equal-Weight on Elanco Animal Health, Raises Price Target to $26 Morgan Stanley analyst Erin Wright maintains Elanco Animal Health (NYSE:ELAN) with a Equal-Weight and raises the price target from $23 to $26.- benzinga.com Elanco Animal Health Announces New Data Published In The Journal Parasites & Vectors Demonstrate That Credelio Quattro Kills Ticks Faster Than Leading Competitors Newly Published Data Found Credelio Quattro:Faster2 Tick1 Speed of Kill: Credelio Quattro is the only product proven to significantly reduce black-legged ticks within 8 hours.i Lotilaner, the active…
benzinga.com Micron To Rally Around 44%? Here Are 10 Top Analyst Forecasts For Thursday Top analysts changed outlook on top names: Intuit downgraded, Alkermes price target raised, Carmax target increased, Sezzle target up, Biogen target raised, Progressive target cut.
benzinga.com TD Cowen Maintains Buy on Elanco Animal Health, Raises Price Target to $32 TD Cowen analyst Steve Scala maintains Elanco Animal Health (NYSE:ELAN) with a Buy and raises the price target from $31 to $32.- benzinga.com Elanco Animal Health Intends To Form Elanco Ventures Elanco Animal Health Incorporated (NYSE:ELAN) today announced plans to establish Elanco Ventures, a dedicated corporate venture capital (CVC) platform designed to support, invest and advance…
benzinga.com Elanco Animal Health Receives USDA Approval Of Its TruCan Ultra Lyme-L4 Combination Vaccine TruCan Ultra Lyme-L4 is the first and only 1/2 mL combination vaccine protecting against both Lyme disease and leptospirosis, all in a low-volume doseBy combining two injections into one, the vaccine…- benzinga.com Elanco Animal Health Reaffirms Commitment To Providing Livestock Producers And Pet Owners With Resources, Treatment Options For Animals Against New World Screwworm Company offers portfolio of treatment options and expert guidance following first confirmed case in the United States New World screwworm has officially reached the United
benzinga.com Jim Cramer Says He Feels 'Something Not Well' At Zoetis, Names A Rival As His Pick Cramer says Zoetis has issues. Prefers this stock in animal health industry. Energy Transfer is in a good position.- benzinga.com Elanco Animal Health Rolls Out Befrena Monoclonal Antibody To Treat Anine Allergic, Atopic Dermatitis Elanco Animal Health Incorporated (NYSE:ELAN) today announced the phased launch of Befrena™ (tirnovetmab), a new anti-IL-31 monoclonal antibody (mAb) injection for treatment of canine allergic and…
- benzinga.com Citigroup Maintains Buy on Elanco Animal Health, Raises Price Target to $31 Citigroup analyst Daniel Grosslight maintains Elanco Animal Health (NYSE:ELAN) with a Buy and raises the price target from $30 to $31.
- benzinga.com JP Morgan Maintains Overweight on Elanco Animal Health, Raises Price Target to $30 JP Morgan analyst Chris Schott maintains Elanco Animal Health (NYSE:ELAN) with a Overweight and raises the price target from $28 to $30.
benzinga.com Earnings Scheduled For May 6, 2026 
benzinga.com Elanco Animal Health Moves Higher On Earnings Strength And Product Momentum Elanco Animal Health rallies after emergency use approvals and Q1 earnings beat, with higher guidance.
benzinga.com Elanco Animal Health Reports Q1 2026 Results: Full Earnings Call Transcript - benzinga.com Elanco Animal Health Sees Q2 Adj EPS $0.25-$0.28 vs $0.29 Est; Sees Sales $1.300B-$1.325B vs $1.319B Est Elanco Animal Health (NYSE:ELAN) is looking for Q2 Adj EPS of $0.25-$0.28 vs $0.29 analyst estimate. sees sales of $1.300 billion-$1.325 billion vs $1.319 billion analyst estimate.
benzinga.com Elanco Animal Health Raises FY2026 Adj EPS Guidance from $1.00-$1.06 to $1.03-$1.09 vs $1.03 Est; Raises FY2026 Sales Guidance from $4.950B-$5.020B to $5.010B-$5.085B vs $5.001B Est Elanco Animal Health (NYSE:ELAN) raises FY2026 Adj EPS guidance from $1.00-$1.06 to $1.03-$1.09 vs $1.03 analyst estimate. Raises FY2026 sales outlook from $4.950 billion-$5.020 billion to $5.010…- benzinga.com Elanco Animal Health Q1 Adj. EPS $0.40 Beats $0.35 Estimate, Sales $1.371B Beat $1.288B Estimate Elanco Animal Health (NYSE:ELAN) reported quarterly earnings of $0.40 per share which beat the analyst consensus estimate of $0.35 by 14.29 percent. This is a 8.11 percent increase over earnings of…
- benzinga.com Elanco Receives FDA Emergency Use Authorization And EPA Emergency Exemption For New World Screwworm Livestock Treatments Ahead Of Potential U.S. Spread Action Prepares Veterinarians and Livestock Producers with Prevention and Treatment Options Prior to Fly Being Detected in the U.S.Federal agencies grant emergency authorizations for New World…
- benzinga.com Citigroup Initiates Coverage On Elanco Animal Health with Buy Rating, Announces Price Target of $30 Citigroup analyst Daniel Grosslight initiates coverage on Elanco Animal Health (NYSE:ELAN) with a Buy rating and announces Price Target of $30.